Market Executive Summary

The global Genome Engineering Editing market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029.

The market is mainly driven by the significant applications of Genome Engineering Editing in various end use industries. The expanding demands from the Agriculture, Medical and Others, are propelling Genome Engineering Editing market. Homologous Recombination, one of the segments analysed in this report, is projected to record CAGR and reach US$ million by the end of the analysis period. Growth in the Meganuclease segment is estimated at CAGR for the next seven-year period.

Genome engineering editing refers to the use of tools such as CRISPR-Cas9 to precisely edit and modify the genome of an organism to achieve specific gene improvement and functional regulation. With the development of genome engineering editing technology, the future trend is to continuously improve and enhance the accuracy and efficiency of editing technology. This includes improving the specificity and accuracy of the CRISPR-Cas9 system, reducing the incidence of non-specific splicing events, and increasing editing efficiency and success.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide

1) Global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends;

2) Global market share and ranking by company;

3) Comprehensive presentation of the global market for Genome Engineering Editing, with both quantitative and qualitative analysis through detailed segmentation;

4) Detailed value chain analysis and review of growth factors essential for the existing market players and new entrants;

5) Emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Genome Engineering Editing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Genome Engineering Editing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Genome Engineering Editing sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Genome Engineering Editing covered in this report include Thermo Fisher Scientific, SIGMA ALDRICH, Dharmacon, Cellectics, CRISPR Therapeutics, AstraZeneca, Bio Rad, Allele Biotech and Recombinetics, etc.

The global Genome Engineering Editing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.

Global Genome Engineering Editing Companies Covered

Thermo Fisher Scientific, SIGMA ALDRICH, Dharmacon, Cellectics, CRISPR Therapeutics, AstraZeneca, Bio Rad, Allele Biotech, Recombinetics, Lonza, GE Healthcare, Editas Medicine, Agilent Technologies, QIAGEN NV.

Global Genome Engineering Editing Market, Segment by Type

Homologous Recombination

Meganuclease

Global Genome Engineering Editing Market, Segment by Application

Agriculture

Medical

Others

Core Chapters

Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter Four: Detailed analysis of Genome Engineering Editing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.

Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter Twelve: Research Finding/Conclusion